Patent details

300626 Product Name: Combinatie van: (a) dextromethorfan, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder dextromethorfanhydrobromide, meer in het bijzonder dextromethorfanhydrobromide monohydraat; en (b) kinidine, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder kinidinesulfaat, meer in het bijzonder kinidinesulfaatdihydraat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300626
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1539166
Status:
SPC in force
Application number:
300626
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/833
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/06/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
22/11/2013
First Marketing Authorization date:
26/06/2013
Grant date:
03/09/2015
Activation date:
17/07/2023
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
22/11/2013
SPC/SPC Extension Expiration Date:
25/06/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
22/11/2013
 
 

 

Name:
AVANIR Pharmaceuticals, Inc.
Address:
20 Enterprise, Suite 200, 92656, Aliso Viejo, CALIFORNIA, United States of America (US)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
22/11/2013
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Opposition

Objection/ Appeal

Request Number:
000004
Filling Date:
15/10/2015
Requestor For Appeal Name:
AVANIR Pharmaceuticals, Inc.
Reason:
SPC Application Rejected
Type:
Objection
Status:
Completed
Decision:
Accepted
Decision Issued Date:
09/03/2016
Decision Summary:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
29/23
Publication date:
19/07/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
VB2
Journal edition number:
10/16
Publication date:
09/03/2016
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention

3

Bulletin Heading:
VB1
Journal edition number:
43/15
Publication date:
21/10/2015
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
SPC
Journal edition number:
2015/36
Publication date:
02/09/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2013/49
Publication date:
04/12/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/07/2026
Annual Fee Number:
24
Annual Fee Amount:
2200 Euro
Last Annual Payment Date:
01/07/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
09/03/2016 Restoration Restoration 2 PDF /6/2/6/0/0/0400300626/docs/300626_7_beschikking c300626.pdf
09/03/2016 Restoration Restoration 1 PDF /6/2/6/0/0/0400300626/docs/300626_14_certificaat c300626.pdf
22/10/2015 Appeal Request appeal 2 PDF /6/2/6/0/0/0400300626/docs/300626_15_appeal20201019031109698.pdf
22/10/2015 Appeal Subsequently filed documents appeal procedure 1 PDF /6/2/6/0/0/0400300626/docs/300626_17_appeal20201019031147343.pdf
15/10/2015 Appeal Request appeal 3 PDF /6/2/6/0/0/0400300626/docs/300626_0_appeal20151019035416774.pdf
03/09/2015 SPC Documents Certificate SPC 1 PDF /6/2/6/0/0/0400300626/docs/300626_11_supplprotectioncertificate20201016025930472.pdf
03/09/2015 Outgoing Correspondence Outgoing Letter 2 PDF /6/2/6/0/0/0400300626/docs/300626_24_outgoingcorrespondence20150903.pdf
31/08/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /6/2/6/0/0/0400300626/docs/300626_6_incomingcorrespondencepaper20210315012145494.pdf
15/10/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/2/6/0/0/0400300626/docs/300626_16_incomingcorrespondencepaper20210315012036435.pdf
29/07/2014 Incoming Correspondence Paper Accompanying letter incoming document 4 PDF /6/2/6/0/0/0400300626/docs/300626_4_incomingcorrespondencepaper20210315011826051.pdf
03/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /6/2/6/0/0/0400300626/docs/300626_2_outgoingcorrespondence20140603.pdf
26/05/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/2/6/0/0/0400300626/docs/300626_22_incomingcorrespondencepaper20210315011707569.pdf
27/02/2014 Outgoing Correspondence Outgoing Letter 2 PDF /6/2/6/0/0/0400300626/docs/300626_1_outgoingcorrespondence20140227.pdf
27/02/2014 Outgoing Correspondence Outgoing Letter 6 PDF /6/2/6/0/0/0400300626/docs/300626_8_outgoingcorrespondence20140227.pdf
27/02/2014 Outgoing Correspondence Outgoing Letter 2 PDF /6/2/6/0/0/0400300626/docs/300626_10_outgoingcorrespondence20140227.pdf
25/11/2013 Application Form First filed application form 3 PDF /6/2/6/0/0/0400300626/docs/300626_3_applicationform20131125.pdf
25/11/2013 SPC Documents Annex SPC 21 PDF /6/2/6/0/0/0400300626/docs/300626_5_supplprotectioncertificate20201016014447193.pdf
25/11/2013 Incoming Correspondence Paper Incoming Correspondence Paper 3 PDF /6/2/6/0/0/0400300626/docs/300626_9_incomingcorrespondencepaper20131125.pdf
25/11/2013 SPC Documents Marketing Authorization SPC 3 PDF /6/2/6/0/0/0400300626/docs/300626_12_supplprotectioncertificate20201016014624489.pdf
25/11/2013 SPC Documents Annex SPC 1 PDF /6/2/6/0/0/0400300626/docs/300626_13_supplprotectioncertificate20201016014252681.pdf
25/11/2013 SPC Documents Summary of the characteristics of the product 33 PDF /6/2/6/0/0/0400300626/docs/300626_18_supplprotectioncertificate20201016015158940.pdf
25/11/2013 SPC Documents Annex SPC 3 PDF /6/2/6/0/0/0400300626/docs/300626_19_supplprotectioncertificate20201016015158996.pdf
25/11/2013 SPC Documents Annex SPC 21 PDF /6/2/6/0/0/0400300626/docs/300626_20_supplprotectioncertificate20201016015159060.pdf
25/11/2013 SPC Documents Annex SPC 1 PDF /6/2/6/0/0/0400300626/docs/300626_21_supplprotectioncertificate20201016015343968.pdf
22/11/2013 Outgoing Correspondence Outgoing Letter 1 PDF /6/2/6/0/0/0400300626/docs/300626_23_outgoingcorrespondence20131122.pdf